HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jae Min Cho Selected Research

site 1 membrane-bound transcription factor peptidase

1/2021Soluble (pro)renin receptor induces endothelial dysfunction and hypertension in mice with diet-induced obesity via activation of angiotensin II type 1 receptor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jae Min Cho Research Topics

Disease

4Obesity
01/2021 - 01/2002
3Neoplasms (Cancer)
07/2022 - 01/2004
2Hepatocellular Carcinoma (Hepatoma)
06/2022 - 04/2002
2Breast Neoplasms (Breast Cancer)
01/2021 - 03/2015
2Fibrosis (Cirrhosis)
12/2020 - 10/2020
2Insulin Resistance
12/2020 - 01/2013
2Hemorrhage
05/2017 - 01/2002
2Diabetes Mellitus
11/2012 - 01/2009
1Hypertension (High Blood Pressure)
01/2021
1Alcoholic Fatty Liver
12/2020
1Hyperemia
01/2019
1Cardiomyopathies (Cardiomyopathy)
01/2019
1Inflammation (Inflammations)
01/2018
1Pain (Aches)
05/2017
1Triple Negative Breast Neoplasms
03/2015
1Neoplasm Metastasis (Metastasis)
03/2015
1Cholangiocarcinoma
12/2014
1Type 2 Diabetes Mellitus (MODY)
08/2014
1Abscess
12/2013
1Mitochondrial Diseases (Mitochondrial Disease)
01/2013
1Insulinoma
06/2010
1Hypertrophy
01/2004
1Paraplegia (Spastic Paraplegia)
11/2003
1Guillain-Barre Syndrome
11/2003
1Carcinoma (Carcinomatosis)
04/2002
1Acute Kidney Injury (Acute Renal Failure)
01/2002

Drug/Important Bio-Agent (IBA)

2Indicators and Reagents (Reagents)IBA
07/2022 - 12/2014
2Pharmaceutical PreparationsIBA
01/2021 - 05/2017
1Sorafenib (BAY 43-9006)FDA Link
06/2022
1LigandsIBA
01/2021
1Trastuzumab (Herceptin)FDA Link
01/2021
1site 1 membrane-bound transcription factor peptidaseIBA
01/2021
1Prorenin ReceptorIBA
01/2021
1Type 1 Angiotensin ReceptorIBA
01/2021
1Amino AcidsFDA Link
12/2020
1Choline (Choline Chloride)IBA
12/2020
1Fibroblast Growth Factors (Fibroblast Growth Factor)IBA
12/2020
1IodineIBA
10/2020
1Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
01/2019
1Beclin-1IBA
01/2019
1Proteins (Proteins, Gene)FDA Link
01/2019
1Lysosomal Membrane ProteinsIBA
01/2019
1Glucose (Dextrose)FDA LinkGeneric
01/2018
1PalmitatesIBA
01/2018
1Anesthetics (Anesthetic Agents)IBA
05/2017
1Epinephrine (Adrenaline)FDA LinkGeneric
05/2017
1AnthracyclinesIBA
03/2015
1Irinotecan (Camptosar)FDA LinkGeneric
03/2015
1Capecitabine (Xeloda)FDA Link
03/2015
1Fluorouracil (Carac)FDA LinkGeneric
03/2015
1taxaneIBA
03/2015
1Taxoids (Taxanes)IBA
03/2015
1Thymidine PhosphorylaseIBA
12/2014
1GemcitabineFDA Link
12/2014
1doxifluridineIBA
12/2014
1Biomarkers (Surrogate Marker)IBA
12/2014
1Cisplatin (Platino)FDA LinkGeneric
12/2014
1Amyloid (Amyloid Fibrils)IBA
08/2014
1Anti-Bacterial Agents (Antibiotics)IBA
12/2013
1fibroblast growth factor 21IBA
01/2013
1Hormones (Hormone)IBA
01/2013
1Insulin (Novolin)FDA Link
01/2013
1Fatty Acids (Saturated Fatty Acids)IBA
01/2013
1CytokinesIBA
11/2012
1Small Interfering RNA (siRNA)IBA
06/2010
1Dual Specificity Phosphatase 1IBA
06/2010
1Adiponectin ReceptorsIBA
01/2009
1GelatinIBA
01/2004
1Vincristine (Oncovin)FDA LinkGeneric
11/2003
1ferumoxides (Feridex)FDA Link
04/2002

Therapy/Procedure

4Therapeutics
06/2022 - 01/2002
3Drug Therapy (Chemotherapy)
03/2015 - 11/2003
2Combination Drug Therapy (Combination Chemotherapy)
03/2015 - 12/2014
2Catheters
12/2013 - 01/2004
1Heart-Assist Devices
01/2019
1Analgesia
05/2017
1Adjuvant Chemotherapy
03/2015
1Splenectomy
12/2013
1Hepatectomy
01/2004
1Lipectomy (Liposuction)
01/2002